6月1日,国家发改委出台了第18轮药品降价方案。此次降价主要是调整67种、涉及300多个剂型规格的抗肿瘤药物价格,平均降幅23%,最大降幅57%。对这一旨在进一步挤压药品流通领域的不合理利润空间的做法,各界有何反应,记者进行了跟踪采访。患者对降价效果持怀疑态度6月2日,记者来到 June 1, the NDRC introduced the first 18 rounds of drug prices program. The price cut is mainly to adjust the 67 kinds of anti-cancer drugs involving more than 300 dosage forms specifications, an average drop of 23%, the largest decline of 57%. This practice aimed at further squeezing the irrational profit margin in the field of drug circulation has caused any reaction from all walks of life. The reporter conducted follow-up interviews. Patients are skeptical of the effect of price cuts June 2, the reporter arrived